x

Posted 17 November, 2021

Trillium Therapeutics Inc. appointed new CEO

CEO Change detected for ticker Nasdaq:TRIL in a 8-K filed on 17 November, 2021.


  On November 17, 2021, in connection with the completion of the Arrangement and following the Effective Time, Jan Skvarka (President, Chief Executive Officer and Principal Executive Officer), Robert Uger (Chief Scientific Officer), Ingmar Bruns (Chief Medical Officer), James Parsons (Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer) and Penka Petrova (Chief Development Officer and Principal Operating Officer) ceased to serve in their capacities as executive officers of Trillium.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of Trillium Therapeutics Inc.
Retail/Wholesale • Wholesalers
PT Triwira Insanlestari Tbk engages in the distribution and supply of safety equipment, technical automotive equipment, machinery and technical hardware. The firm operates through the following segments: Safety and Equipment, Machinery and Automation and Hoist and Lever. It also involves in the mining and energy businesses. The company was founded by Tommy Lybianto on October 26, 1992 and is headquartered in Jakarta, Indonesia.
Market Cap
N/A
View Company Details
Trillium Therapeutics Inc. by TradingView
Relevant filing section
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On November 17, 2021, in connection with the completion of the Arrangement and following the Effective Time, Jan Skvarka (President, Chief Executive Officer and Principal Executive Officer), Robert Uger (Chief Scientific Officer), Ingmar Bruns (Chief Medical Officer), James Parsons (Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer) and Penka Petrova (Chief Development Officer and Principal Operating Officer) ceased to serve in their capacities as executive officers of Trillium. Following the Effective Time, Deborah Baron will serve as President and each of Colum Lane, Brian McMahon, Andrew Muratore, Alison O'Neill, Bryan Supran and Tiffany Trunko will serve as Vice Presidents.


Also, effective as of the Effective Time, each then-member of the board of directors of Trillium, consisting of Jan Skvarka, Luke Beshar, Michael Kamarck, Catherine Mackey, Helen Tayton-Marton, Scott Myers, Paolo Pucci, and Paul Walker, resigned from the Trillium board of directors and all committees thereof. Effective immediately following these resignations, Deborah Baron and Andrew Muratore became the directors of Trillium.